Simpson Thacher Represents Underwriters in IPO of Veracyte, Inc.
11.05.13
This is only gets display when printing
Simpson Thacher recently represented the underwriters, led by joint book-running managers Morgan Stanley & Co. LLC and Leerink Swann LLC, in the initial public offering by Veracyte, Inc. (“Veracyte”) of 5,000,000 shares of common stock. Veracyte’s common stock is listed on the NASDAQ Global Market under the ticker symbol “VCYT.”
Veracyte is a diagnostics company pioneering the field of molecular cytology to improve patient outcomes and lower healthcare costs.
The Simpson Thacher team included Bill Hinman, Jean Park and Alex Coffin (Capital Markets); Tristan Brown, Linda Barrett and Grace Wirth (Executive Compensation and Employee Benefits); Noah Leibowitz and Katherine Helm (Intellectual Property); Jennie Getsin (FINRA and Blue Sky); and Michael Cardella (Tax).